Assessment of Anti–Factor Xa Levels of Patients Undergoing Colorectal Surgery Given Once-Daily Enoxaparin Prophylaxis: A Clinical Study Examining Enoxaparin Pharmacokinetics

IMPORTANCE: Between 4% and 12% of patients undergoing colorectal surgery and receiving enoxaparin, 40 mg per day, have a postoperative venous thromboembolism (VTE) event. An improved understanding of why “breakthrough” VTE events occur despite guideline-compliant prophylaxis is an important patient...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Surg
Autors principals: Pannucci, Christopher J., Fleming, Kory I., Bertolaccini, Corinne B., Prazak, Ann Marie, Huang, Lyen C., Pickron, T. Bartley
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2019
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6537829/
https://ncbi.nlm.nih.gov/pubmed/31116389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamasurg.2019.1165
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars